Hana Pharm Co Ltd
KRX:293480
Hana Pharm Co Ltd
Tax Provision
Hana Pharm Co Ltd
Tax Provision Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hana Pharm Co Ltd
KRX:293480
|
Tax Provision
-₩4.1B
|
CAGR 3-Years
19%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Yuhan Corp
KRX:000100
|
Tax Provision
-₩6.3B
|
CAGR 3-Years
38%
|
CAGR 5-Years
19%
|
CAGR 10-Years
13%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Tax Provision
₩154.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Tax Provision
-₩30.8B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Tax Provision
-₩16.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-19%
|
|
|
C
|
Celltrion Pharm Inc
KOSDAQ:068760
|
Tax Provision
-₩6B
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-27%
|
|
Hana Pharm Co Ltd
Glance View
Hana Pharm Co., Ltd. engages in the research, development, and manufacture of pharmaceutical products. The company is headquartered in Hwaseong, Gyeonggi-Do and currently employs 657 full-time employees. The company went IPO on 2018-10-02. The company’s main products include cardiovascular drugs involves hypertension and hyperlipidemia medicines, as well as blood circulation improvement drugs; analgesics for severe pain and anesthetics for surgery and sedation; as well as gastrointestinal drugs such as peptic ulcer treatment and antispasmodics. The firm also provides antibiotics, dermatology analgesics, antipyretics and anti-inflammatory drugs.
See Also
What is Hana Pharm Co Ltd's Tax Provision?
Tax Provision
-4.1B
KRW
Based on the financial report for Dec 31, 2024, Hana Pharm Co Ltd's Tax Provision amounts to -4.1B KRW.
What is Hana Pharm Co Ltd's Tax Provision growth rate?
Tax Provision CAGR 5Y
9%
Over the last year, the Tax Provision growth was 26%. The average annual Tax Provision growth rates for Hana Pharm Co Ltd have been 19% over the past three years , 9% over the past five years .
You don't have any saved screeners yet